Camlin Fine Sciences Ltd (CAMLINFINE) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Camlin Fine Sciences Ltd. reported improved performance in a challenging economic environment, particularly impacted by Chinese pricing and supply pressures.
- Revenue increased by 2% to Rs. 433.49 crores from Rs. 422.97 crores in the previous quarter.
- Gross margins improved from 48% to 50%, and operational EBITDA increased from 10% to 12%.
- The company experienced a loss due to foreign exchange volatility, impacting other income compared to the previous quarter's gain.
- The recently completed rights issue received an overwhelming response, and the proceeds were used to repay debt, improving liquidity.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.